Omicron Breakthrough Infection after Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is usually asymptomatic or mild and appears to be poorly immunogenic at least in unvaccinated individuals. Here, we found that health care workers vaccinated with 2 doses of Sputnik V and a booster dose o...
| Autores: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | Argentina |
| Institución: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositorio: | CONICET Digital (CONICET) |
| Idioma: | inglés |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/212995 |
| Acceso en línea: | http://hdl.handle.net/11336/212995 |
| Access Level: | acceso abierto |
| Palabra clave: | COVID-19 NEUTRALIZING ANTIBODIES OMICRON SARS-COV-2 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| Sumario: | Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is usually asymptomatic or mild and appears to be poorly immunogenic at least in unvaccinated individuals. Here, we found that health care workers vaccinated with 2 doses of Sputnik V and a booster dose of ChAdOx1 mount a vigorous neutralizing-Antibody response after Omicron breakthrough infection. |
|---|